A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Xiaonan Hong et al.|Journal of Hematology & Oncology|2020Cited by 50
Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotectionBing Xu, Wuqiang Zhu, Fan Li et al.|iScience|2022Cited by 8